Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve Stenosis | 19 | 2023 | 378 | 1.970 |
Why?
|
| Transcatheter Aortic Valve Replacement | 18 | 2023 | 245 | 1.880 |
Why?
|
| Heart Valve Prosthesis Implantation | 10 | 2023 | 461 | 1.030 |
Why?
|
| Heart Valve Prosthesis | 10 | 2023 | 331 | 1.020 |
Why?
|
| Aortic Valve | 14 | 2023 | 483 | 0.720 |
Why?
|
| Postoperative Complications | 10 | 2023 | 3142 | 0.430 |
Why?
|
| Interleukin-17 | 2 | 2011 | 129 | 0.410 |
Why?
|
| Intestinal Mucosa | 3 | 2011 | 794 | 0.350 |
Why?
|
| Chemokine CCL20 | 1 | 2011 | 16 | 0.350 |
Why?
|
| Colon | 2 | 2011 | 370 | 0.350 |
Why?
|
| Aortic Valve Insufficiency | 5 | 2020 | 158 | 0.340 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2011 | 55 | 0.340 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 85 | 0.330 |
Why?
|
| Epithelium, Corneal | 2 | 2011 | 171 | 0.330 |
Why?
|
| Interleukins | 1 | 2011 | 129 | 0.330 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 206 | 0.320 |
Why?
|
| Stroke | 7 | 2023 | 1085 | 0.290 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 444 | 0.280 |
Why?
|
| Bioprosthesis | 2 | 2020 | 121 | 0.280 |
Why?
|
| Cornea | 1 | 2011 | 598 | 0.250 |
Why?
|
| Treatment Outcome | 17 | 2023 | 13028 | 0.200 |
Why?
|
| Aged, 80 and over | 13 | 2021 | 7102 | 0.190 |
Why?
|
| Neutrophils | 3 | 2022 | 361 | 0.190 |
Why?
|
| Patient Readmission | 3 | 2023 | 425 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2011 | 32 | 0.170 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2011 | 123 | 0.170 |
Why?
|
| P-Selectin | 2 | 2011 | 69 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 9 | 2011 | 4757 | 0.160 |
Why?
|
| Inflammation | 4 | 2011 | 1517 | 0.160 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 164 | 0.160 |
Why?
|
| Follow-Up Studies | 9 | 2023 | 5409 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2020 | 1131 | 0.150 |
Why?
|
| Survival Rate | 7 | 2021 | 2192 | 0.150 |
Why?
|
| Cardiac Catheterization | 4 | 2016 | 664 | 0.150 |
Why?
|
| Disease Susceptibility | 2 | 2011 | 293 | 0.150 |
Why?
|
| Risk Factors | 10 | 2023 | 10941 | 0.150 |
Why?
|
| Colitis | 2 | 2011 | 165 | 0.150 |
Why?
|
| Weight Loss | 3 | 2011 | 515 | 0.140 |
Why?
|
| Blood Platelets | 2 | 2011 | 320 | 0.140 |
Why?
|
| Wound Healing | 2 | 2011 | 477 | 0.130 |
Why?
|
| Mice, Knockout | 5 | 2011 | 3863 | 0.130 |
Why?
|
| Hemodynamics | 3 | 2015 | 855 | 0.120 |
Why?
|
| Mice | 10 | 2011 | 18507 | 0.120 |
Why?
|
| Canada | 4 | 2019 | 337 | 0.120 |
Why?
|
| DNA Methylation | 3 | 2011 | 1122 | 0.120 |
Why?
|
| Epigenesis, Genetic | 2 | 2011 | 753 | 0.110 |
Why?
|
| Health Care Rationing | 1 | 2015 | 63 | 0.110 |
Why?
|
| Echocardiography | 5 | 2020 | 1129 | 0.110 |
Why?
|
| Obesity | 3 | 2011 | 2391 | 0.110 |
Why?
|
| Patient Selection | 2 | 2015 | 737 | 0.110 |
Why?
|
| Male | 20 | 2021 | 64922 | 0.110 |
Why?
|
| Severity of Illness Index | 5 | 2022 | 3091 | 0.100 |
Why?
|
| Aged | 11 | 2021 | 21406 | 0.100 |
Why?
|
| Registries | 2 | 2022 | 1572 | 0.100 |
Why?
|
| CD11c Antigen | 2 | 2011 | 40 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 845 | 0.100 |
Why?
|
| Female | 17 | 2021 | 70712 | 0.090 |
Why?
|
| Dietary Fats | 2 | 2010 | 279 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 822 | 0.090 |
Why?
|
| Atrial Fibrillation | 2 | 2019 | 758 | 0.090 |
Why?
|
| Animals | 10 | 2011 | 34882 | 0.090 |
Why?
|
| Humans | 24 | 2023 | 132061 | 0.090 |
Why?
|
| Receptors, CCR6 | 1 | 2011 | 6 | 0.090 |
Why?
|
| Chemokine CXCL1 | 1 | 2011 | 15 | 0.090 |
Why?
|
| Genes, T-Cell Receptor delta | 1 | 2011 | 8 | 0.090 |
Why?
|
| Adipose Tissue | 2 | 2011 | 504 | 0.090 |
Why?
|
| Monocytes | 2 | 2011 | 342 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 1284 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 29 | 0.080 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 50 | 0.080 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 44 | 0.080 |
Why?
|
| Metabolic Syndrome | 2 | 2011 | 364 | 0.080 |
Why?
|
| Time Factors | 5 | 2021 | 6448 | 0.080 |
Why?
|
| Bacteria | 2 | 2011 | 524 | 0.080 |
Why?
|
| Metagenome | 1 | 2011 | 146 | 0.080 |
Why?
|
| Epigenomics | 1 | 2011 | 191 | 0.080 |
Why?
|
| Incidence | 4 | 2020 | 3380 | 0.080 |
Why?
|
| Intra-Abdominal Fat | 1 | 2009 | 61 | 0.080 |
Why?
|
| Cause of Death | 3 | 2017 | 510 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2011 | 394 | 0.080 |
Why?
|
| United States | 7 | 2019 | 11658 | 0.070 |
Why?
|
| Computational Biology | 2 | 2011 | 874 | 0.070 |
Why?
|
| Piperidines | 1 | 2010 | 235 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 420 | 0.070 |
Why?
|
| Leukocytes | 1 | 2009 | 209 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 242 | 0.070 |
Why?
|
| Skin | 1 | 2011 | 537 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2010 | 333 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 487 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2011 | 2674 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 1798 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1347 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2011 | 439 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2010 | 527 | 0.070 |
Why?
|
| Liver | 2 | 2011 | 1797 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2011 | 903 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2011 | 327 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2017 | 3736 | 0.060 |
Why?
|
| Chemokine CCL2 | 3 | 2011 | 118 | 0.060 |
Why?
|
| Models, Biological | 1 | 2011 | 1443 | 0.060 |
Why?
|
| Prosthesis Design | 2 | 2019 | 670 | 0.060 |
Why?
|
| Germany | 2 | 2015 | 59 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2019 | 1573 | 0.050 |
Why?
|
| Length of Stay | 2 | 2019 | 1379 | 0.050 |
Why?
|
| Sternotomy | 1 | 2021 | 43 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2438 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 1454 | 0.040 |
Why?
|
| Blood Cell Count | 2 | 2011 | 68 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2022 | 362 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2020 | 63 | 0.040 |
Why?
|
| Comorbidity | 2 | 2015 | 1609 | 0.040 |
Why?
|
| Quality of Life | 2 | 2021 | 2137 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5164 | 0.030 |
Why?
|
| Health Status | 1 | 2020 | 402 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2017 | 113 | 0.030 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2017 | 78 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1436 | 0.030 |
Why?
|
| British Columbia | 1 | 2016 | 11 | 0.030 |
Why?
|
| Age Factors | 2 | 2014 | 2912 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2017 | 6567 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2016 | 105 | 0.030 |
Why?
|
| Medical Futility | 1 | 2015 | 38 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 309 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 427 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2016 | 166 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 257 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 377 | 0.030 |
Why?
|
| Benchmarking | 1 | 2015 | 138 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2014 | 172 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 435 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 460 | 0.020 |
Why?
|
| Isomerism | 1 | 2011 | 26 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2011 | 40 | 0.020 |
Why?
|
| Elasticity | 1 | 2011 | 92 | 0.020 |
Why?
|
| Betaine | 1 | 2011 | 21 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1247 | 0.020 |
Why?
|
| Choline | 1 | 2011 | 51 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2011 | 62 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2011 | 96 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2014 | 519 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 62 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1491 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2015 | 1057 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 223 | 0.020 |
Why?
|
| Heart Failure | 1 | 2023 | 2393 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2009 | 39 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 65 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2011 | 254 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 865 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2011 | 211 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 236 | 0.020 |
Why?
|
| Chemokines | 1 | 2009 | 129 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 4688 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2009 | 94 | 0.020 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2011 | 142 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 636 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 85 | 0.020 |
Why?
|
| Folic Acid | 1 | 2011 | 288 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 5009 | 0.020 |
Why?
|
| Weight Gain | 1 | 2010 | 381 | 0.020 |
Why?
|
| Energy Intake | 1 | 2010 | 493 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 791 | 0.020 |
Why?
|
| Pedigree | 1 | 2011 | 1719 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1694 | 0.020 |
Why?
|
| Cell Movement | 1 | 2010 | 889 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1548 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2009 | 697 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 1124 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 9957 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 3418 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1738 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 3406 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 17419 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 7566 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 28964 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 31568 | 0.010 |
Why?
|